Abstract:Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death. Early detection of AD and its prodromal stage, mild cognitive impairment (MCI) which can be either stable (sMCI) or progressive (pMCI), is highly desirable for effective treatment planning and tailoring therapy. Recent studies recommended using multimodal data fusion of genetic (single nucleotide polymorphisms, SNPs) and neuroimaging data (magnetic resonance imaging (MRI) and positron emission tomography (PET)) to discriminate AD/MCI from normal control (NC) subjects. However, missing multimodal data in the cohort under study is inevitable. In addition, data heterogeneity between phenotypes and genotypes biomarkers makes learning capability of the models more challenging. Also, the current studies mainly focus on identifying brain disease classification and ignoring the regression task. Furthermore, they utilize multistage for predicting the brain disease progression. To address these issues, we propose a novel multimodal neuroimaging and genetic data fusion for joint classification and clinical score regression tasks using the maximum number of available samples in one unified framework using convolutional neural network (CNN). Specifically, we initially perform a technique based on linear interpolation to fill the missing features for each incomplete sample. Then, we learn the neuroimaging features from MRI, PET, and SNPs using CNN to alleviate the heterogeneity among genotype and phenotype data. Meanwhile, the high learned features from each modality are combined for jointly identifying brain diseases and predicting clinical scores. To validate the performance of the proposed method, we test our method on 805 subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Also, we verify the similarity between the synthetic and real data using statistical analysis. Moreover, the experimental results demonstrate that the proposed method can yield better performance in both classification and regression tasks. Specifically, our proposed method achieves accuracy of 98.22%, 93.11%, and 97.35% for NC vs. AD, NC vs. sMCI, and NC vs. pMCI, respectively. On the other hand, our method attains the lowest root mean square error and the highest correlation coefficient for different clinical scores regression tasks compared with the state-of-the-art methods.

3D Convolutional Neural Networks-Based Multiclass Classification of Alzheimer’s and Parkinson’s Diseases Using PET and SPECT Neuroimaging Modalities

Joint Multiclass Classification of the subjects of Alzheimer's and Parkinson's Diseases through Neuroimaging Modalities and Convolutional Neural Networks.

Early-Stage Alzheimer's Disease Categorization Using PET Neuroimaging Modality and Convolutional Neural Networks in the 2D and 3D Domains

Classification of Subjects of Mild Cognitive Impairment and Alzheimer’s Disease Through Neuroimaging Modalities and Convolutional Neural Networks

Multiclass Classification of Initial Stages of Alzheimer's Disease Through Neuroimaging Modalities and Convolutional Neural Networks

Multimodal 3D Convolutional Neural Networks for Classification of Brain Disease Using Structural MR and FDG-PET Images.

On Improved 3D-Cnn-based Binary and Multiclass Classification of Alzheimer’s Disease Using Neuroimaging Modalities and Data Augmentation Methods

Classification of Initial Stages of Alzheimer’s Disease Through Pet Neuroimaging Modality and Deep Learning: Quantifying the Impact of Image Filtering Approaches

Diagnosis of Alzheimer’s Disease Via Multi-Modality 3D Convolutional Neural Network

Classification of Alzheimer’s Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images

Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer’s Disease Diagnosis

CNNs Based Multi-Modality Classification for AD Diagnosis

Enhancing Alzheimer's Disease Classification Using 3D Convolutional Neural Network and Multilayer Perceptron Model with Attention Network

Classification of Alzheimer’s Disease by Cascaded Convolutional Neural Networks Using PET Images

Diagnosis of Alzheimer's Disease via Multi-modality 3D Convolutional Neural Network

Deep Convolutional Neural Network based Classification of Alzheimer's Disease using MRI data

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

Deep learning application for the classification of Alzheimer’s disease using 18F-flortaucipir (AV-1451) tau positron emission tomography

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images

Attention-based 3D CNN with Multi-layer Features for Alzheimer's Disease Diagnosis using Brain Images

Understanding 3D CNN Behavior for Alzheimer's Disease Diagnosis from Brain PET Scan